(19)
(11) EP 4 408 392 A1

(12)

(43) Date of publication:
07.08.2024 Bulletin 2024/32

(21) Application number: 22797936.6

(22) Date of filing: 29.09.2022
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/42(2017.01)
A61K 38/00(2006.01)
A61K 47/02(2006.01)
A61L 31/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/00; A61K 9/0024; A61K 47/42; A61K 47/02; A61K 31/704; A61P 35/00; C08J 3/075; C08J 2389/00; A61K 35/13
(86) International application number:
PCT/US2022/045273
(87) International publication number:
WO 2023/055963 (06.04.2023 Gazette 2023/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 29.09.2021 US 202163249949 P
30.09.2021 US 202163250441 P

(71) Applicants:
  • Boston Scientific Scimed, Inc.
    Maple Grove, MN 55311-1566 (US)
  • Mayo Foundation for Medical Education and Research
    Rochester, Minnesota 55905 (US)
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Oakland, CA 94607-5200 (US)

(72) Inventors:
  • KIM, Hanjun
    Oakland, California 94607-5200 (US)
  • XU, Chun
    Oakland, California 94607-5200 (US)
  • JABBARZADEH, Ehsan
    Columbia, South Carolina 29201 (US)
  • OKLU, Rahmi
    Rochester, Minnesota 55905 (US)
  • KHADEMHOSSEINI, Alizera
    Oakland, California 94607-5200 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)

   


(54) INJECTABLE SHEAR-THINNING HYDROGEL CONTAINING THERAPEUTIC AGENT FOR ENHANCED TUMOR THERAPY